News
BSX
106.11
-0.03%
-0.03
PBH or BSX: Which Is the Better Value Stock Right Now?
NASDAQ · 17h ago
Parnassus Growth Equity Fund Q4 And 2024 Annual Investment Commentary
Seeking Alpha · 21h ago
Weekly Report: what happened at BSX last week (0210-0214)?
Weekly Report · 1d ago
SYK Trades Below 52-Week High: Should You Buy, Hold or Sell the Stock?
Barchart · 1d ago
Moderna remains the most shorted stock among S&P 500 healthcare stocks in the first month of 2025
Seeking Alpha · 3d ago
PACB Stock Down Following In-Line Q4 Earnings, Revio Shipments Fall
NASDAQ · 3d ago
DVA Stock Down in Pre-Market Despite Q4 Earnings Beat, Margins Expand
NASDAQ · 3d ago
Janus Henderson Mid Cap Growth Managed Account Q4 2024 Commentary
Seeking Alpha · 3d ago
Is Now the Right Time to Hold on to Charles River Stock?
NASDAQ · 3d ago
Boston Scientific Executive Makes a Major Stock Move
TipRanks · 4d ago
Janus Henderson Global Life Sciences Diversified ADR Managed Account Q4 2024 Commentary
Seeking Alpha · 4d ago
WST Stock Declines in Pre-Market Despite Q4 Earnings Beat, Margins Down
NASDAQ · 4d ago
HOLX's New Offerings Likely to Revive Stock Amid Macro Woes
NASDAQ · 4d ago
QuidelOrtho Stock Gains Following Q4 Earnings Beat, Margins Contract
NASDAQ · 4d ago
TMO Stock Set to Gain From The Launch of New Spatial Imaging System
NASDAQ · 4d ago
Lead Independent Director Edward Ludwig Sold A Bunch Of Shares In Boston Scientific
Simply Wall St · 4d ago
Zacks.com featured highlights include Brinker International, Business First Bancshares, AZEK, Celestica and Boston Scientific
NASDAQ · 5d ago
Janus Henderson Enterprise Fund Q4 2024 Commentary
Seeking Alpha · 5d ago
Janus Henderson Global Life Sciences Fund Q4 2024 Commentary
Seeking Alpha · 5d ago
It’s time for investors to rotate, with opportunities down the market cap – Piper Sandler
Seeking Alpha · 5d ago
More
Webull provides a variety of real-time BSX stock news. You can receive the latest news about Boston Scien Cp through multiple platforms. This information may help you make smarter investment decisions.
About BSX
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. It also owns the transcarotid artery revascularization (TCAR) platform.